Vulva choriocarcinoma

Choriocarcinoma vulva is an exceptional location of gestational trophoblastic tumors. We report the case of a female patient of 23 years who had vulvar mass, painful, sitting at the large right lip and measured five centimeters in diameter. Pelvic ultrasound was normal. Beta-h-CG (human chorionic go...

Full description

Bibliographic Details
Main Author: Houssine Boufettal
Format: Article
Language:English
Published: The Pan African Medical Journal 2016-08-01
Series:The Pan African Medical Journal
Subjects:
Online Access: https://www.panafrican-med-journal.com/content/article/24/328/pdf/328.pdf
_version_ 1818500955194261504
author Houssine Boufettal
author_facet Houssine Boufettal
author_sort Houssine Boufettal
collection DOAJ
description Choriocarcinoma vulva is an exceptional location of gestational trophoblastic tumors. We report the case of a female patient of 23 years who had vulvar mass, painful, sitting at the large right lip and measured five centimeters in diameter. Pelvic ultrasound was normal. Beta-h-CG (human chorionic gonadotrophin) quantitative plasma were highly increased. The staging. The biopsy of the mass objectified choriocarcinoma of vulvar. A methotrexate-based agent chemotherapy was introduced. The outcome was favorable. With a decline of 24 months, no recurrence was noted. Choriocarcinoma vulva is a clinical form of trophoblastic tumors which one must think before all lesions with positive plasma beta-h-CG, especially in a woman of childbearing age and the waning of a pregnancy event. A patient aged 23 presented with a history spontaneous miscarriage which occurred five months earlier consulted for vulvar mass, painful, which gradually increased in size. On examination, the mass was sitting at the large right lip, it was inflammatory, firm and tender to palpation and measured five centimeters in diameter. Pelvic ultrasound was normal. Beta-h-CG (human chorionic gonadotrophin) quantitative plasma were highly increased to 562 000 IU / ml. The staging featuring a thoraco-abdominopelvic CT scan, chest X-ray and ultrasound abdomen and pelvis was normal. The biopsy of the mass objectified choriocarcinoma of vulvar. A methotrexate-based agent chemotherapy was introduced. The evolution was marked by the gradual decline of the mass until it disappears in four months. Plasma beta-h-CG had regressed and were normalized after three months of treatment. The outcome was favorable. With a decline of 24 months, no recurrence was noted.
first_indexed 2024-12-10T20:49:38Z
format Article
id doaj.art-ead5908a03aa4b3494b71294976a35f5
institution Directory Open Access Journal
issn 1937-8688
1937-8688
language English
last_indexed 2024-12-10T20:49:38Z
publishDate 2016-08-01
publisher The Pan African Medical Journal
record_format Article
series The Pan African Medical Journal
spelling doaj.art-ead5908a03aa4b3494b71294976a35f52022-12-22T01:34:08ZengThe Pan African Medical JournalThe Pan African Medical Journal1937-86881937-86882016-08-012432810.11604/pamj.2016.24.328.1048210482Vulva choriocarcinomaHoussine BoufettalChoriocarcinoma vulva is an exceptional location of gestational trophoblastic tumors. We report the case of a female patient of 23 years who had vulvar mass, painful, sitting at the large right lip and measured five centimeters in diameter. Pelvic ultrasound was normal. Beta-h-CG (human chorionic gonadotrophin) quantitative plasma were highly increased. The staging. The biopsy of the mass objectified choriocarcinoma of vulvar. A methotrexate-based agent chemotherapy was introduced. The outcome was favorable. With a decline of 24 months, no recurrence was noted. Choriocarcinoma vulva is a clinical form of trophoblastic tumors which one must think before all lesions with positive plasma beta-h-CG, especially in a woman of childbearing age and the waning of a pregnancy event. A patient aged 23 presented with a history spontaneous miscarriage which occurred five months earlier consulted for vulvar mass, painful, which gradually increased in size. On examination, the mass was sitting at the large right lip, it was inflammatory, firm and tender to palpation and measured five centimeters in diameter. Pelvic ultrasound was normal. Beta-h-CG (human chorionic gonadotrophin) quantitative plasma were highly increased to 562 000 IU / ml. The staging featuring a thoraco-abdominopelvic CT scan, chest X-ray and ultrasound abdomen and pelvis was normal. The biopsy of the mass objectified choriocarcinoma of vulvar. A methotrexate-based agent chemotherapy was introduced. The evolution was marked by the gradual decline of the mass until it disappears in four months. Plasma beta-h-CG had regressed and were normalized after three months of treatment. The outcome was favorable. With a decline of 24 months, no recurrence was noted. https://www.panafrican-med-journal.com/content/article/24/328/pdf/328.pdf choricarcinomavulvatrophoblastic neoplasiachemotherapyfertility
spellingShingle Houssine Boufettal
Vulva choriocarcinoma
The Pan African Medical Journal
choricarcinoma
vulva
trophoblastic neoplasia
chemotherapy
fertility
title Vulva choriocarcinoma
title_full Vulva choriocarcinoma
title_fullStr Vulva choriocarcinoma
title_full_unstemmed Vulva choriocarcinoma
title_short Vulva choriocarcinoma
title_sort vulva choriocarcinoma
topic choricarcinoma
vulva
trophoblastic neoplasia
chemotherapy
fertility
url https://www.panafrican-med-journal.com/content/article/24/328/pdf/328.pdf
work_keys_str_mv AT houssineboufettal vulvachoriocarcinoma